Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne
Journal of Cosmetic Dermatology · 2026-04 · 25 (4)
DOI: 10.1111/jocd.70812 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 31.03.2026. Verfasst von Nello Tommasino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. While isotretinoin remains the gold standard for moderate‐to‐severe cases, its adverse effects and teratogenicity underscore the need for alternative systemic therapies.
Objective
To review emerging systemic treatments for acne beyond isotretinoin, evaluating their efficacy, safety, and potential clinical applications.
Methods
A narrative review was conducted through PubMed, Scopus, and Web of Science, including studies from January 2015 to June 2025. Eligible publications focused on systemic treatments for moderate‐to‐severe acne, excluding topical‐only and non‐peer‐reviewed studies.
Results
Promising alternatives include the narrow‐spectrum antibiotic sarecycline, hormonal agents such as spironolactone and combined oral contraceptives, and metformin in patients with polycystic ovary syndrome. Biologic therapies, phosphodiesterase‐4 inhibitors, oral probiotics, and novel agents like montelukast and CAMP factor vaccines are also under investigation. These treatments show varying degrees of efficacy and improved safety profiles, but most lack head‐to‐head comparisons with isotretinoin.
Conclusion
Several systemic options beyond isotretinoin have emerged, showing potential in specific subgroups or as adjunctive therapies. However, further large‐scale comparative studies are needed to define their roles within evidence‐based acne management algorithms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Nello Tommasino, Luca Potestio, Maddalena Napolitano
Zitieren
APA
Tommasino, N., Annunziata, M. C., Potestio, L., & Napolitano, M. (2026). Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70812
Vancouver
Tommasino N, Annunziata MC, Potestio L, Napolitano M. Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70812
BibTeX
@article{Tommasino2026,
author = {Tommasino, Nello and Annunziata, Maria Carmela and Potestio, Luca and Napolitano, Maddalena},
title = {Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/jocd.70812}
}
EUVIMED